S
Seth M. Cohen
Researcher at University of California, San Diego
Publications - 511
Citations - 39017
Seth M. Cohen is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Neutrino & Medicine. The author has an hindex of 91, co-authored 476 publications receiving 33642 citations. Previous affiliations of Seth M. Cohen include Massachusetts Institute of Technology & École Polytechnique Fédérale de Lausanne.
Papers
More filters
Journal ArticleDOI
The impact of laryngeal disorders on work-related dysfunction.
TL;DR: To determine the short‐term disability (STD) and lost work productivity related to laryngeal disorders, a large number of patients were diagnosed with either a central nervous system disorder or a combination of the two.
Journal ArticleDOI
Morning or evening bright light treatment of winter depression? The significance of hypersomnia.
TL;DR: Improvement in the depression as measured by the Hamilton Depression Rating scores was greater with morning light compared with evening lights, and Hypersomnia was associated with a superior response to morning light.
Journal ArticleDOI
Single-Atom Ligand Changes Affect Breathing in an Extended Metal–Organic Framework
TL;DR: The pyridine component of 1 does not interfere with the solvothermal synthetic procedure, and hence both 1 and 2 form similar isoreticular MOFs, and gas sorption data showed that BMOF-1-dcppy displayed a very large hysteresis with N-2 and CO(2) suggestive of possible framework flexibility.
Journal ArticleDOI
Emerging trends in metalloprotein inhibition
Matthieu Rouffet,Seth M. Cohen +1 more
TL;DR: Some emerging trends and recent findings in the area of metalloprotein inhibitor discovery and development are described, calling for more input and consideration from the bioinorganic community to address questions traditionally confined to the medicinal chemistry community.
Journal ArticleDOI
Investigation of self-immolative linkers in the design of hydrogen peroxide activated metalloprotein inhibitors.
TL;DR: A series of self-immolative boronic ester protected methyl salicylates and metal-binding groups with various linking strategies have been investigated for their use in the design of matrix metalloproteinase proinhibitors.